Boston Scientific Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Quarter	Current	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	May '26 May 22, 2026	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jun '23 Jun 30, 2023	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022	Jun '22 Jun 30, 2022	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Sep '21 Sep 30, 2021
Market Cap	85,540	93,265	141,404	144,715	159,004	149,222	131,707	123,474	113,285	100,612	84,684	77,311	79,203	71,920	66,321	55,466	53,353	63,314	60,522	61,819
Market Cap Growth	-46.20%	-37.50%	7.36%	17.20%	40.36%	48.31%	55.53%	59.71%	43.03%	39.89%	27.69%	39.38%	48.45%	13.59%	9.58%	-10.28%	-12.54%	15.31%	18.84%	12.99%
Enterprise Value	96,528	103,081	151,114	155,276	170,292	160,039	142,272	132,105	121,181	109,144	93,169	85,501	88,089	80,614	74,328	63,712	62,049	72,294	67,662	68,957
Last Close Price	57.55	62.75	95.35	97.63	107.41	100.88	89.32	83.80	77.01	68.49	57.81	52.80	54.09	50.03	46.27	38.73	37.27	44.29	42.48	43.39
PE Ratio	23.91	26.26	49.15	52.21	63.93	73.64	71.46	69.26	62.61	57.55	54.03	64.39	90.15	84.80	102.82	92.21	64.26	83.57	59.00	56.35
Forward PE	16.49	18.11	28.71	31.28	36.41	35.25	33.08	32.80	32.18	30.44	26.76	25.25	26.97	26.21	24.51	20.67	20.36	25.01	23.73	25.22
PEG Ratio	1.07	1.10	1.65	2.26	2.98	2.88	2.42	2.68	2.75	2.51	2.19	2.05	2.18	2.38	2.30	1.81	1.76	1.78	1.64	1.56
PS Ratio	4.22	4.52	7.04	7.48	8.60	8.50	7.86	7.76	7.44	6.84	5.95	5.62	5.91	5.51	5.23	4.41	4.33	5.21	5.09	5.39
PB Ratio	3.28	3.61	5.84	6.19	7.09	6.72	6.05	5.96	5.56	5.05	4.39	4.09	4.35	4.03	3.77	3.14	3.09	3.78	3.64	3.76
P/TBV Ratio	3.33	3.63	5.89	6.24	7.16	6.78	6.11	6.02	5.61	5.09	4.43	4.12	4.32	4.05	3.80	3.16	3.11	3.81	3.67	3.78
P/FCF Ratio	25.02	26.84	38.66	37.84	45.63	49.51	49.79	57.27	61.53	59.25	47.26	45.56	52.49	60.13	70.70	99.94	89.97	68.23	45.99	38.21
P/OCF Ratio	20.03	21.48	31.19	31.28	37.11	39.15	38.34	42.06	43.04	40.62	33.83	32.86	37.27	40.54	43.46	46.34	44.76	41.44	32.36	29.94
EV/Sales Ratio	4.68	5.00	7.53	8.02	9.21	9.12	8.50	8.30	7.96	7.42	6.54	6.22	6.57	6.18	5.86	5.07	5.03	5.94	5.69	6.01
EV/EBITDA Ratio	17.55	19.87	30.34	32.26	38.16	38.67	36.74	35.27	32.75	29.65	26.33	25.61	29.49	27.97	26.69	24.90	24.09	30.20	29.52	31.91
EV/EBIT Ratio	23.51	27.18	41.83	44.84	54.10	56.17	54.66	52.59	49.02	44.26	39.76	39.57	48.24	46.46	45.07	44.65	42.62	55.83	56.43	64.51
EV/FCF Ratio	27.78	29.66	41.31	40.61	48.86	53.10	53.79	61.27	65.82	64.28	51.99	50.38	58.38	67.40	79.24	114.80	104.64	77.90	51.42	42.62
Debt / Equity Ratio	0.42	0.42	0.47	0.49	0.51	0.50	0.49	0.52	0.51	0.53	0.47	0.47	0.49	0.50	0.51	0.49	0.52	0.56	0.55	0.55
Debt / EBITDA Ratio	2.13	7.60	9.61	8.35	10.03	9.08	10.50	10.48	12.72	10.85	10.15	8.96	11.15	10.76	12.84	13.37	12.69	12.57	19.29	13.79
Debt / FCF Ratio	3.17	64.50	11.29	9.98	10.26	31.95	9.12	13.23	16.07	-	13.19	17.52	17.58	113.99	15.02	26.83	44.42	-	42.76	25.38
Net Debt / Equity Ratio	0.37	0.37	0.39	0.44	0.49	0.48	0.48	0.41	0.38	0.42	0.43	0.42	0.47	0.47	0.46	0.47	0.50	0.54	0.43	0.43
Net Debt / EBITDA Ratio	1.85	6.60	7.96	7.43	9.57	8.49	10.10	8.07	9.22	8.47	9.18	8.00	10.62	10.08	11.50	12.84	12.30	12.14	15.19	10.83
Net Debt / FCF Ratio	2.76	56.00	9.35	8.89	9.79	29.90	8.76	10.19	11.64	-552.67	11.94	15.64	16.75	106.77	13.46	25.77	43.05	-50.17	33.68	19.94
Asset Turnover	0.12	0.12	0.13	0.13	0.13	0.12	0.12	0.12	0.12	0.11	0.11	0.11	0.11	0.10	0.10	0.10	0.10	0.10	0.10	0.09
Inventory Turnover	2.10	0.53	0.56	0.54	0.60	0.54	0.55	0.51	0.52	0.52	0.53	0.53	0.53	0.55	0.58	0.58	0.64	0.61	0.66	0.59
Quick Ratio	0.98	0.98	0.90	0.77	0.65	0.68	0.46	0.85	0.95	0.94	0.63	0.67	0.56	0.65	0.76	0.62	0.56	0.51	0.87	0.90
Current Ratio	1.90	1.90	1.62	1.51	1.37	1.45	1.08	1.48	1.61	1.66	1.32	1.42	1.29	1.40	1.51	1.45	1.31	1.18	1.48	1.55
Return on Equity (ROE)	5.52%	5.52%	2.88%	3.39%	3.68%	3.15%	2.71%	2.34%	1.65%	2.58%	2.72%	2.75%	1.51%	1.80%	0.82%	1.10%	1.57%	0.68%	0.58%	2.62%
Return on Assets (ROA)	3.00%	3.00%	1.90%	2.09%	1.76%	2.00%	1.74%	1.43%	1.13%	1.57%	1.72%	1.74%	0.99%	1.19%	0.44%	0.86%	1.01%	1.05%	0.45%	1.07%
Return on Invested Capital (ROIC)	3.37%	3.37%	2.17%	2.42%	2.03%	2.28%	1.97%	1.65%	1.31%	1.80%	1.97%	1.95%	1.10%	1.33%	0.51%	0.99%	1.17%	1.20%	0.53%	1.27%
Return on Capital Employed (ROCE)	2.94%	2.94%	2.32%	3.01%	2.41%	2.76%	2.14%	2.38%	1.72%	2.23%	1.98%	2.40%	1.79%	1.94%	1.42%	1.27%	1.53%	1.68%	0.65%	1.40%
Earnings Yield	4.10%	3.81%	2.03%	1.92%	1.56%	1.36%	1.40%	1.44%	1.60%	1.74%	1.85%	1.55%	1.11%	1.18%	0.97%	1.08%	1.56%	1.20%	1.69%	1.77%
FCF Yield	4.00%	3.73%	2.59%	2.64%	2.19%	2.02%	2.01%	1.75%	1.63%	1.69%	2.12%	2.20%	1.91%	1.66%	1.41%	1.00%	1.11%	1.47%	2.17%	2.62%
Buyback Yield / Dilution	-0.42%	-0.13%	-0.38%	-0.54%	-0.63%	-0.77%	-0.90%	-0.84%	-1.92%	-2.47%	-2.39%	-2.43%	-1.28%	-0.53%	-0.43%	-0.31%	-0.37%	-0.53%	0.31%	-0.33%
Total Shareholder Return	-0.42%	-0.13%	-0.38%	-0.54%	-0.63%	-0.77%	-0.90%	-0.84%	-1.92%	-2.47%	-2.39%	-2.43%	-1.28%	-0.53%	-0.43%	-0.31%	-0.37%	-0.53%	0.31%	-0.33%

Updated May 1, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q